The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of PD-1 inhibitors as first- and second- line treatments for advanced gastroesophageal cancers: A network meta-analysis of phase III clinical trials.
 
Laercio Lopes Da Silva
No Relationships to Disclose
 
Robin Park
No Relationships to Disclose
 
Pedro Nazareth Aguiar
Honoraria - Boehringer Ingelheim; Merck
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Dr. Reddy's Laboratories
 
Eduardo Edleman Saul
No Relationships to Disclose
 
Benjamin Haaland
Consulting or Advisory Role - AstraZeneca; National Kidney Foundation; Prometic Life Sciences; Value Analytics Labs
Travel, Accommodations, Expenses - Flatiron Health
 
Gilberto Lopes
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - Abbvie (Inst); adaptimmune (Inst); AstraZeneca; AstraZeneca (Inst); Bavarian Nordic (Inst); Blueprint Medicines (Inst); BMS (Inst); EMD Serono (Inst); G1 Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Lilly (Inst); Lucence; Merck Sharp & Dohme (Inst); NOVARTIS (Inst); Pfizer (Inst); Rgenix (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; E.R. Squibb Sons, LLC; Janssen; Pfizer